Ying Qiu

1.2k total citations
30 papers, 689 citations indexed

About

Ying Qiu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ying Qiu has authored 30 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Ying Qiu's work include Sarcoma Diagnosis and Treatment (5 papers), Vascular Tumors and Angiosarcomas (3 papers) and Diabetes Treatment and Management (3 papers). Ying Qiu is often cited by papers focused on Sarcoma Diagnosis and Treatment (5 papers), Vascular Tumors and Angiosarcomas (3 papers) and Diabetes Treatment and Management (3 papers). Ying Qiu collaborates with scholars based in China, United States and Japan. Ying Qiu's co-authors include Katsuyuki Aozasa, Howard G. Birnbaum, Takafumi Ueda, Yasuhiko Tomita, Kenichiro Hamada, Eiichi Morii, Kristy Iglay, Binglin Zhang, Alex Z. Fu and Kimberly G. Brodovicz and has published in prestigious journals such as The EMBO Journal, Cancer and Clinical Cancer Research.

In The Last Decade

Ying Qiu

29 papers receiving 674 citations

Peers

Ying Qiu

ONCOL

PRM

SURGE

EPIDE

Yongping Xu China

Simona Mihai Romania

Michael W. Lee United States

Xue Yu China

Weijun Qin China

Carolina Valdiviezo United States

Liyan Huang China

Xuan Zheng China

Young Joo Kim South Korea

Yongping Xu China

Ying Qiu

236 ×1.0

202 ×1.9

ONCOL

78 ×0.8

PRM

69 ×0.9

SURGE

58 ×0.8

EPIDE

Citations per year, relative to Ying Qiu Ying Qiu (= 1×) peers Yongping Xu

Countries citing papers authored by Ying Qiu

Since Specialization

Citations

This map shows the geographic impact of Ying Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Qiu more than expected).

Fields of papers citing papers by Ying Qiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Qiu. The network helps show where Ying Qiu may publish in the future.

Co-authorship network of co-authors of Ying Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Qiu. A scholar is included among the top collaborators of Ying Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Qiu. Ying Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dai, Zhicheng, Xiaohui Wang, Yinghao Zhang, Ying Qiu, & Jie Liu. (2024). A highly malignant succinate dehydrogenase A‑deficient renal cell carcinoma with bone metastasis misdiagnosed as hereditary leiomyomatosis and renal cell carcinoma: A case report. Oncology Letters. 28(2). 351–351.

Zheng, Xin, Qi Jiang, Ying Qiu, et al.. (2023). FBXO38 regulates macrophage polarization to control the development of cancer and colitis. Cellular and Molecular Immunology. 20(11). 1367–1378. 17 indexed citations

Zheng, Xin, Jun Xiao, Qi Jiang, et al.. (2022). AKT2 reduces IFNβ1 production to modulate antiviral responses and systemic lupus erythematosus. The EMBO Journal. 41(6). e108016–e108016. 13 indexed citations

Xie, Bo, Ying Qiu, Juan Zhou, et al.. (2022). Establishment of an acquired lorlatinib-resistant cell line of non-small cell lung cancer and its mediated resistance mechanism. Clinical & Translational Oncology. 24(11). 2231–2240. 1 indexed citations

Guo, Chenchen, Ruijie Wan, Yayi He, et al.. (2022). Therapeutic targeting of the mevalonate–geranylgeranyl diphosphate pathway with statins overcomes chemotherapy resistance in small cell lung cancer. Nature Cancer. 3(5). 614–628. 61 indexed citations

Kiki, Claude, Ying Qiu, Qi Wang, et al.. (2022). Induced aging, structural change, and adsorption behavior modifications of microplastics by microalgae. Environment International. 166. 107382–107382. 36 indexed citations

Tang, Jackson, et al.. (2016). Evaluating Expected Medication Costs and Budget Impact of Systemic Therapies for Unresectable/Metastatic Melanoma. Value in Health. 19(3). A143–A143. 2 indexed citations

Shi, Dongmei, Yaxin Zhao, Hongxia Yan, et al.. (2016). Antifungal effects of undecylenic acid on the biofilm formation of Candida albicans. International Journal of Clinical Pharmacology and Therapeutics. 54(5). 343–353. 44 indexed citations

Qiu, Ying, et al.. (2014). Human umbilical cord mesenchymal stromal cells suppress MHC class II expression on rat vascular endothelium and prolong survival time of cardiac allograft.. Europe PMC (PubMed Central). 14 indexed citations

10.

Shi, Dongmei, Haiyan Zheng, Hongxia Yan, et al.. (2014). Paeoniflorin inhibits the maturation and immunostimulatory function of allergen-induced murine dendritic cells. International Immunopharmacology. 19(2). 221–232. 17 indexed citations

11.

Fu, Alex Z., Kristy Iglay, Ying Qiu, et al.. (2014). Risk characterization for urinary tract infections in subjects with newly diagnosed type 2 diabetes. Journal of Diabetes and its Complications. 28(6). 805–810. 61 indexed citations

12.

Jiao, Liang, Ying Qiu, Na Liu, et al.. (2014). [Expression of CD133 in primary retroperitoneal leiomyosarcoma and its relationship with Ki-67].. PubMed. 94(16). 1241–4. 2 indexed citations

13.

DiBonaventura, Marco, et al.. (2010). Multinational Internet-based survey of patient preference for newer oral or injectable Type 2 diabetes medication. Patient Preference and Adherence. 4. 397–397. 47 indexed citations

14.

Ivanova, Jasmina, Howard G. Birnbaum, Yohanne Kidolezi, et al.. (2009). Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States. Epilepsia. 51(5). 838–844. 45 indexed citations

15.

Tian, Tian, Masayoshi Inoue, Jun‐ichiro Ikeda, et al.. (2009). Tumorigenic Role of Orphan Nuclear Receptor NR0B1 in Lung Adenocarcinoma. American Journal Of Pathology. 175(3). 1235–1245. 28 indexed citations

16.

Yu, Shanfa, et al.. (2009). [Effect of occupational stress on hypertension].. PubMed. 27(12). 706–10. 6 indexed citations

17.

Hamada, Kenichiro, Yasuhiko Tomita, Ying Qiu, et al.. (2008). 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II. Annals of Nuclear Medicine. 22(8). 699–705. 24 indexed citations

18.

Hamada, Kenichiro, Yasuhiko Tomita, Ying Qiu, et al.. (2008). 18F-FDG PET analysis of schwannoma: increase of SUVmax in the delayed scan is correlated with elevated VEGF/VPF expression in the tumors. Skeletal Radiology. 38(3). 261–266. 28 indexed citations

19.

Ch’ng, Ewe Seng, Yasuhiko Tomita, Binglin Zhang, et al.. (2007). Prognostic significance of CD100 expression in soft tissue sarcoma. Cancer. 110(1). 164–172. 36 indexed citations

20.

Tomita, Yasuhiko, Takaya Morooka, Yoshihiko Hoshida, et al.. (2007). Reassessment of the 1993 Osaka grading system for localized soft tissue sarcoma in Japan.. PubMed. 26(6C). 4665–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact